764
Views
48
CrossRef citations to date
0
Altmetric
Research Article

Melatonin releasing PLGA micro/nanoparticles and their effect on osteosarcoma cells

&
Pages 53-63 | Received 06 Apr 2015, Accepted 15 Oct 2015, Published online: 25 Nov 2015

References

  • Ardakani JM, Walker J, Qujeq D. Serum factors induced the nuclear location of annexin V in the human osteosarcoma cell line (MG-63). Iran Biomed J, 2000;4(4):117–22.
  • Billiau A, Edy VG, Heremans H, Van Damme J, Desmyter J, Georgiades JA, Sz Somer AP. Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother, 1977;12(1):11–15.
  • Casado-Zapico S, Rodriguez-Blanco J, Garcia-Santos G, Martin M, Sanchez-Sanches AM, Antolin I, Rodriguez C. Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: Potentiation of the extrinsic apoptotic pathway. J. Pineal Res, 2010;48:72–80.
  • Cheng Y, Cai L, Jiang P, Wang J, Gao C, Feng H, Wang C, Pan H, Yang Y. SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells. Eur J Pharmacol, 2013;715(1–3):219–29.
  • Chitkara D, Kumar N. BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs. Pharm Res, 2013;30:2396–409.
  • Cooper DL, Harirforoosh S. Design and optimization of PLGA-based diclofenac loaded nanoparticles. Plos One, 2014;9(1):e87326–35.
  • Cotterill SJ, Wright CM, Pearce MS, Craft AW. Stature of young people with malignant bone tumors. Pediatr Blood Cancer, 2004;42:59–63.
  • Cutando A, Lopez-Vamverde A, Arias-Santiago S, De Vincente J, De Diego RG. Role of melatonin in cancer treatment. Anticancer Res, 2012;32:2747–54.
  • Dam DHM, Lee JH, Sisco PN, Co DT, Zhang M, Wasielewski MR, Odom TW. Direct observation of nanoparticle-cancer cell nucleus interactions. ACS Nano, 2012;6(4):3318–26.
  • De Jong WH, Borm PJA. Drug delivery and nanoparticles: Applications and hazards. Int J Nanomedicine, 2008;3(2):133–49.
  • Ekmekcioglu C. Melatonin receptors in humans: Biological role and clinical relevance. Biomed Pharmacother, 2006;60:97–108.
  • Han X-R, Sun Y, Bai X-Z. The anti-tumor role and mechanism of integrated and truncated PDCD5 proteins in osteosarcoma cells. Cell Signal, 2012;24:1713–21.
  • Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 1963;52:1145–9.
  • Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation (I) theoretical consideration. Ind Eng Chem, 1931;23:923–31.
  • Hua X, Tan S, Bandara HMHN, Fu Y, Liu S, Smyth HDC. Externally controlled triggered-release of drug from PLGA micro and nanoparticles. PLoS One, 2014;9(12):e114271
  • Irmak G, Demirtaş TT, Çetin Altındal D Çalış M, Gümüşderelioğlu M. Sustained release of 17β-estradiol stimulates osteogenic differentiation of adipose tissue-derived mesenchymal stem cells on chitosan-hydroxyapatite scaffolds. Cells Tissues Organs, 2014;199:37–50.
  • Kreuter J, Ramge P, Petrov V, Hamm S, Gelperina SE, Engelhardt B, Alvautdin R, von Briesen H, Begley DJ. Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res, 2003;20:409–16.
  • Kutlu C, Çakmak AS, Gümüşderelioğlu M. Double-effective chitosan scaffold-PLGA nanoparticle system for brain tumour therapy: In vitro study. J Microencapsul, 2014;31(7):700–7.
  • Kwon H-Y, Lee J-Y, Choi S-W, Jang Y, Kim J-H. Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method. Colloids Surf A Physicochem Eng Aspects, 2001;182:123–30.
  • Lissoni P, Barni S, Mandala M, Ardizzoia A, Paolorossi F, Vaghi M, Longarini R, Malugani F, Tancini G. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer, 1999;35:1688–92.
  • Liu L, Zhu Y, Xu Y, Reiter RJ. Melatonin delays cell proliferation by inducing G1 and G2/M phase arrest in a human osteoblastic cell line hFOB 1.19. J Pineal Res, 2011;50:222–31.
  • Liu L, Xu Y, Reiter RJ. Melatonin inhibits the proliferation of human osteosarcoma cell line MG-63. Bone, 2013;55:432–8.
  • Luchetti F, Canonico B, Bartolini D, Arcangeletti M, Ciffolilli S, Murdolo G, Piroddi M, Papa S, Reiter RJ, Galli F. Melatonin regulates mesenchymal stem cell differentiation: A review. J Pineal Res, 2014;56(4):382–97.
  • Marques DR, Santos LA, Schopf LF, Fraga JCS. Analysis of poly(lactic-co-glycolic acid)/poly(isoprene) polymeric blend for application as biomaterial. Polimeros, 2013;23(5):579–84.
  • Mittal G, Sahana DK Bhardwaj V, Kumar MNVR. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release, 2007;119:77–85.
  • Musumeci T, Bucolo C, Carbonea C, Pignatelloa R, Drago F, Puglisi G. Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits. Int J Pharm, 2013;440:135–40.
  • Olivier JC, Fenart L, Chauvet R, Pariat C, Cecchelli R, Covet W. Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity. Pharm Res, 1999;16:1836–42.
  • Parveen S, Sahoo SK. Polymeric nanoparticles for cancer therapy. J Drug Target, 2008;16(2):108–23.
  • Sahana DK, Mittal G, Bhardwaj V, Ravi Kumar MNV. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci, 2008;97(4):1530–42.
  • Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C, Reiter RJ. Melatonin uses in oncology: Breast cancer prevention and reduction of the side effects of chemotherapy and radiation. Expert Opin Investig Drugs, 2012;21:819–31.
  • Schaffazick SR, Pohlmann AR, Mezzaliraa G, Guterres SS. Development of nanocapsule suspensions and nanocapsule spray-dried powders containing melatonin. J Braz Chem Soc, 2006;17(3):562–9.
  • Shoaib MH, Tazeen J, Merchant HA, Yousuf RI. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak J Pharm Sci, 2006;19(2):119–24.
  • Singhvi G, Singh M. Review: In-vitro drug release characterization models. Int J Pharm Sci Res, 2011;2(1):77–84.
  • Stevanovi M, Uskokovi D. Poly(lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins. Curr Nanosci, 2009;5:1–15.
  • Tan D-X, Hardeland R, Manchester LC, Korkmaz A, Ma S, Rosales-Corral S, Reiter RJ. Functional roles of melatonin in plants, and perspectives in nutritional and agricultural science. J Exp Bot, 2012;63(2):577–97.
  • Uhrich KE, Cannizzaro SM, Langer RS. Polymeric systems for controlled drug release. Chem Rev, 1999;99:3181–98.
  • Xin Z-F, Shen C-C, Tao L-J, Yan S-G, Wu H-B. Gambogic acid inhibits invasion of osteosarcoma via upregulation of TIMP-1. Int J Mol Med, 2013;31:105–12.
  • Zhang L, Zhang J, Ling A, Peng Y, Chang H, Su P, Huang D. Sustained release of melatonin from poly (lactic-co-glycolic acid) (PLGA) microspheres to induce osteogenesis of human mesenchymal stem cells in vitro. J Pineal Res, 2013;54:24–32.
  • Zhao W, Lu X, Liu Y, Liu C, Yang B, Hong H, Wang G, Zeng F. Effect of size and processing method on the cytotoxicity of realgar nanoparticles in cancer cell lines. Int J Nanomedicine, 2011;6:1569–77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.